Cerus Corporation
CERS
#7074
Rank
A$0.90 B
Marketcap
A$4.49
Share price
0.64%
Change (1 day)
112.61%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2025 (TTM): -A$11.51 Million

According to Cerus Corporation's latest financial reports the company's current earnings are A$0.19 Billion. In 2024 the company made an earning of -A$16.95 Million, an increase over its 2023 earnings that were of -A$41.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$11.51 Million-32.11%
2024 -A$16.95 Million-58.95%
2023 -A$41.29 Million-20.74%
2022 -A$52.09 Million-25.7%
2021 -A$70.11 Million-11.99%
2020 -A$79.66 Million-14%
2019 -A$92.63 Million21.73%
2018 -A$76.09 Million-0.65%
2017 -A$76.59 Million-10.96%
2016 -A$86.02 Million4.24%
2015 -A$82.52 Million50.99%
2014 -A$54.66 Million-10.08%
2013 -A$60.79 Million184.13%
2012 -A$21.4 Million-7.91%
2011 -A$23.23 Million
2009 -A$32.81 Million-24.69%
2008 -A$43.57 Million-25.2%
2007 -A$58.24 Million330.54%
2006 -A$13.53 Million1.49%
2005 -A$13.33 Million-61.02%
2004 -A$34.2 Million
2002 -A$84.58 Million10.02%
2001 -A$76.88 Million34.25%
2000 -A$57.27 Million61.02%
1999 -A$35.57 Million-18.81%
1998 -A$43.81 Million93.08%
1997 -A$22.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$5.33 B-51,806.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$20.85 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.35 B-3,569.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.54 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA